NIDA Diversity Supplement Program: Professional & Career Development Program |
|
The goal of the NIDA Diversity Supplement Program is to enhance the diversity of the addiction workforce by providing administrative supplements to exiting NIH research grants for post-bacs, pre-docs, post-docs and early-stage investigators that have been shown to be underrepresented in the biomedical workforce (eligibility also includes individuals with disabilities and those from disadvantaged backgrounds).
The program offers 2-3 years of support, while trainees gain the research experience, preliminary data, and other training needed to apply for independent grant funding. Supplements provide salary, fringe benefits, funds for supplies and travel. Please apply to the diversity supplement FOA, PA-21-071. PIs with HIV/AIDS-related grants are particularly encouraged to apply.
Application Deadline for FY2023: May 9, 2023.
Please reach out to Angela Holmes (angela.holmes2@nih.gov) with any questions you may have about the program or to discuss your plans for submitting a diversity supplement application to NIDA.
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
Get Ready for the 2023 Annual CTN Steering Committee Meeting!
The 2023 CTN Annual Steering Committee Meeting is being held in-person at the Bethesda North Marriott Hotel and Conference Center (book your reservation here!) in Rockville, Maryland, from April 24-26, 2023.
For those unable to attend in person, all plenary sessions and some ancillary sessions will be broadcast via Zoom. The level of interaction available virtually will vary by session.
Important Links
Please contact the LMCi Logistics Team at ctnsupport@leedmci.com with questions. We are excited about being back in person and look forward to seeing you at this important meeting! |
CTN Trial Progress
 Randomizations for Active Studies as of the April 17 Trial Progress Report.
CTN-0080 - Enrolled 139
CTN-0096 - Enrolled 3
CTN-0098 - Enrolled 130
CTN-0099 - Enrolled 1479
CTN-0099-A-1 - Enrolled 96
CTN-0100
Discontinuation - Enrolled 136
Retention - Enrolled 758
CTN-0101 - Enrolled 200
CTN-0107 - Enrolled 132
CTN-0108 - Enrolled 80
CTN-0110 - Enrolled 1
CTN-0116 - Enrolled 73
|
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
 Narcan (Naloxone) Nasal Spray Approved for Over-the-Counter Use
On March 29, 2023, the U.S. Food and Drug Administration (FDA) approved Narcan, 4mg naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use -- the first naloxone product approved for use without a prescription.
Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment for opioid overdose.
Read the complete press release here.
Learn more about naloxone on NIDA's Naloxone DrugFacts page.
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
News from the Western States Node
 CTN Western States Node investigators Dan Hartung and Elizabeth Waddell recently published findings from their CDC-funded project, Reducing Overdose After Release from Incarceration (PI: Waddell) that demonstrate risk of fatal and non-fatal opioid overdose risk is 10x greater among Oregon adults releasing from prison than in the state’s general population. Risk is even higher among women, those with documented substance use disorder and mental health treatment needs, and in the two weeks post release. Read the article in JSAT here.
These findings are already driving policy discussions in Oregon and were covered in local media, emphasizing the need to start treatment prior to release and to allocate resources for more intentional release planning that connects adults in custody to community treatment. Check out the news reports here:
|
News from the New England Consortium Node
NIDA News Release:
Buprenorphine initiation in the ER found safe and effective for individuals with OUD who use fentanyl. NIDA News, March 30, 2023.
Referencing findings:
D’Onofrio G, Hawk KF, Perrone J, et al. Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl. JAMA Netw Open. 2023;6(3):e236108.
New Publication:
Kropp FB, Smid MC, Lofwall MR, Wachman EM, Martin PR, Murphy SM, Wilder CM, Winhusen TJ. Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study. J Subst Use Addict Treat. 2023 Apr 4;149:209030. doi: 10.1016/j.josat.2023.209030. PMID: 37023858.
|
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
New in the CTN Dissemination Library
 Collaborative Care Programs for Pregnant and Postpartum Individuals with Opioid Use Disorder: Organizational Characteristics of Sites Participating in the NIDA CTN0080 MOMs Study. Kropp FB, et al. Journal of Substance Use and Addiction Treatment 2023;149:209030. CTN-0080
Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A Stepped Wedge Hybrid Type 1 Effectiveness-Implementation Study. Greiner MG, et al. Contemporary Clinical Trials 2023 (in press). CTN-0097
Optimizing Recruitment and Retention in Substance Use Disorder Research in Emergency Departments. Worth L, et al. West J Emerg Med 2023 (in press). CTN-0047
Repurposing Ketamine to Treat Cocaine Use Disorder: Integration of Artificial Intelligence-Based Prediction, Expert Evaluation, Clinical Corroboration, and Mechanism of Action Analyses. Gao X, et al. Addiction 2023 (in press). CTN-0114
Differential Symptom Weighting in Estimating Empirical Thresholds for Underlying PTSD Severity: Toward a “Platinum” Standard for Diagnosis? Morgan-Lopez A, et al. Int J Methods Psychiatr Res 2023;31963. CTN-0015
Estimating the Impact of Stimulant Use on Initiation of Buprenorphine and Extended-Release Naltrexone in Two Clinical Trials and Real-World Populations. Cook RR, et al. Addict Sci Clin Pract 2023;18:11. CTN-0051, CTN-0067
CTN Webinar: Research 101: Introduction to Clinical Trials: The Basics. Kim M & Vasquez M. Produced by the National Drug Abuse Treatment Clinical Trials Network’s Clinical Coordinating Center, March 3, 2023.
Risk of Experiencing an Overdose Event for Patients Undergoing Treatment with Medication for Opioid Use Disorder. Brandt L, et al. Am J Psychiatry 2023 (in press). CTN-0027, CTN-0030, CTN-0051
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
Upcoming Webinars
 April 18, 2023 (12pm MT)
The Greater Intermountain Node (GIN): Where We Were, Where We Are, and Where We Will Be
In this presentation, Dr. Gordon will describe the origination, present status, and future opportunities of the CTN Greater Intermountain Node (GIN). He will describe the mission and aims of GIN, as well as the three studies originating from the Node and six studies hosted by it. Dr. Gordon will emphasize the remarkable research and clinical collaboration across the University of Utah campus and greater Intermountain area. He will also discuss the robust mentored training of the GIN and look forward to how the GIN will evolve in the future.
Find out more and connect to the GIN webinar here.
May 19, 2023 (11am ET)
Getting Evidence-Based Treatments to Youth and Families Who are Involved in the Juvenile Legal System (CTN Youth SIG)
Dr. Ashli J. Sheidow’s services research examines methods and tools for getting substance use interventions to youth with juvenile legal system involvement. She will present lessons learned, with a focus on a task-shifting study with juvenile probation officers delivering contingency management treatment to youth and their parents/caregivers.
The presentation will include insights into training and support for different providers, as well as lessons learned about services research design and methods.
Find out more and connect to the Youth SIG Webinar here.
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·
· · · · · · · · · · · · · · · · · · · · · · ·
   
|
Free Telementoring Program Brings Research-Based Practices & Skills to Health Care Pros Working with People who Use Alcohol